AzTrials
AzTrials

AgingNCT04630418

NanoSilk Cosmo: Evaluation of a Novel Silk Complex on Biophysical Parameters Related to Skin Aging

A study testing NanoSilk Cosmo in people with Aging, run by University of Colorado, Denver at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Silk is a naturally occurring protein polymer that is approved for medical use by the U.S Food and Drug Administration (FDA). Silk fibroin fiber biomaterial has shown promising results for tissue regeneration demonstrated through in vivo and in vitro animal models. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
NanoSilk Cosmo
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteUnited States
Study dates
1 May 2021to 1 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male, female, and gender non-binary
  • Age 18 years and older
  • Any race or ethnicity
  • Those with evidence of age-related skin changes.

Who cannot join

  • <18 years of age
  • Pregnant
  • Decisionally challenged

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Colorado Anschutz Health and Wellness Center

    Aurora, Colorado, 80045

Other trials in United States

About this study

Silk is a naturally occurring protein polymer that is approved for medical use by the U.S Food and Drug Administration (FDA). Silk fibroin fiber biomaterial has shown promising results for tissue regeneration demonstrated through in vivo and in vitro animal models. The investigators of this study have previously shown that patients' report improvement in common skin aging findings including wrinkles, sagginess, and dry skin. The investigators will continue this assessment of patients' skin perception as well as add on objective measures of skin resilience, elasticity, and hydration.

The investigators will provide participants with a demographic survey, and the FACE-Q survey, a validated survey, prior to administration of NanoSilk Cosmo, to assess perception of aging, satisfaction with facial appearance, satisfaction with skin. The participant will undergo baseline evaluation of several objective measures of skin hydration, elasticity and overall healthy using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7). The participants will be provided with 30ml of the NanoSilk Cosmo and with extensive instruction on administration of the product.

Participants will return to clinic after 4 weeks of using the product to perform the FACE-Q and re-evaluation of several objective measures of the skin using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7).

Read the detailed description

Skin aging is characterized by atrophy, decreased elasticity, wrinkling, impaired strength, and altered metabolic and reparative responses. The etiology of these changes is multifactorial and includes intrinsic factors such as age, genetics, metabolism, and nutrition, as well as extrinsic or environmental effects like Ultraviolet (UV) radiation and air pollution. It has been noted that there is increased fragility of the skin with age due to flattening of the dermo-epidermal junction and decreased biosynthetic capacity of fibroblasts, all leading to decreased skin resilience and an undesirable cosmetic appearance of the skin.

Recently, the use of silk to reverse or repair some of these aging processes has gained significant interest. Silk is a natural protein polymer that is approved for medical use by the U.S. Food and Drug Administration and Bombyx mori (B. mori) silk is considered a non-animal product (EU Council Directive 93/42/EEC, rule 17). Importantly it is biocompatible, non-inflammatory, and non-cytotoxic. There are two important components of silk that are derived from the B. mori worm, both of which are proteins - fibroin and sericin. In simple terms, sericin, which represents about 30% of the entire cocoon, functions as a glue to hold the fibroin fibers together while blocking UV rays and providing moisture. The fibroin, approximately 70% of the cocoon, is composed of two proteins which interestingly have similar amino acid compositions to Natural Moisturizing Factor which is found in the stratum corneum of human skin and helps retain moisture in the skin. The stratum corneum is of key importance to the skin's ability to hold water and maintain skin integrity which is critical for maintaining a youthful appearance.

Besides the moisture retention effects noted above, one of the theories behind the effectiveness of silk on the skin is that the silk fibroin nanofibers are able to promote cell adhesion and allows type I collagen to spread within epidermal keratinocytes and fibroblasts. New data suggest that if a patient has a higher ratio of collagen type I to collagen type III that these patients will have better outcomes after aesthetic facial surgery, which highlights the key role of collagen in the skin.

The investigators will provide participants with the FACE-Q survey, a validated survey, prior to administration of NanoSilk Cosmo, to assess perception of aging, satisfaction with facial appearance, and satisfaction with skin. The participant will undergo baseline evaluation of several objective measures of skin hydration, elasticity and overall healthy using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7). The participants will be provided with 30ml of the NanoSilk Cosmo and with extensive instruction on administration of the product.

Participants will return to clinic after 4 weeks of using the product to perform the FACE-Q and re-evaluation of several objective measures of the skin using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7).

Courage+Khazaka Corneometer Probe: By evaluating the capacitance through the skin this will serve as a reflection of moisture content in the skin. The corneometer is not significantly affected by stales or residues of topicals applied to the skin. Additionally, it provides very quick measurements (1 sec), continuous measurements, and the measurement depth is very small to capture the stratum corneum and avoid deeper skin structures (blood vessels). The Visioscan measures an integral characteristic of skin, and included metric in the clinical experiment. It is medical grade (degree of calibration) and will provide the most accurate data for researchers.

The probe will be placed on the skin before and after use of NanoSilk Cosmo and measure the data points noted above.

Courage+Khazaka Electronic GmbH Cutometer dual MPA 580: This device will measure viscoelasticity of the skin using negative pressure to mechanically deform the skin. The penetration depth is determined by a non-contact optical measuring system within the probe. The resistance of the skin to the negative pressure (firmness) and its ability to return to its original position (elasticity) are displayed as curves (penetration depth in mm/time) in real time. The measurement allows for information about the elastic and mechanical properties of skin surface and to objectively quantify a property of skin aging. The Cutometer measures an integral characteristic of skin and included metric in the clinical experiment. It is medical grade (degree of calibration) and will provide the most accurate data for researchers.

The probe will be placed on the skin before and after use of NanoSilk Cosmo and measure the data points noted above.

VISIA-CA GEN 7(Consultation System): VISIA multi-point positioning system and live image overlay provides complete data surface and subsurface skin conditions. Skin conditions included in analysis are hyperpigmentation, hypopigmentation, inflammation, wrinkles, topography, UV damage, vascularity (spider veins), and porphyrins.

The participant will place their face in the instrument and have their photo taken both before and after use of NanoSilk Cosmo.

Conditions
Aging
Being tested
NanoSilk Cosmo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NanoSilk CosmoOther

    Participant will receive 30 mL of NanoSilk Cosmo jar.

Study groups in NCT04630418
Study groupRoleWhat they receive
NanoSilk CosmoExperimentalParticipants will receive a 30 mL jar of NanoSilk Cosmo
Receives: Other: NanoSilk Cosmo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective patient perception of skin

    Evaluate patient's perception of satisfaction with skin before and after application of NanoSilk Cosmo using surveys designed to target and answer these questions. Copies of these surveys are below.

    Scale Titles: NanoSilk Cosmo Initial Survey and NanoSilk Cosmo Completion Survey

    There are no minimum or maximum values of this scale, therefore there is no high or low score. This is a scale to determine the demographics and use patterns of those who use NanoSilk Cosmo. Additionally, it will give the option for feedback on the product and ask participants to evaluate the effect the product had on their skin.

    Measured: 6 months

  2. Change in skin hydration levels

    To perform a prospective clinical trial to quantitatively assess the effects of NanoSilk Cosmo solution on the hydration status of the skin using the Courage + Khazaka Electronic Corneometer which uses a capacitance measurement of a dielectric medium that changes with increased or decreased hydration in the stratum corneum layer of the skin.

    Measured: 6 months

  3. Change in skin viscoelasticity levels

    To perform a prospective clinical trial to quantitatively assess the effects of NanoSilk Cosmo solution on the viscoelasticity of the skin using the Courage + Khazaka Electronic GmbH Cutometer which uses negative pressure to deform the skin and then measures its ability to return to the original position. These measurements are then displayed on a curve for which normal skin has been previously established.

    Measured: 6 months

  4. Change in skin surface topography

    To perform a prospective clinical trial to quantitatively assess the effects of NanoSilk Cosmo solution on the skin surface topography using VISIA Gen 7. This device uses a non-invasive photograph and then through a series or different lighting on this photograph evaluates common skin surface topography concerns such as spots, pores, wrinkles, texture, porphyrins, UV spots, red areas, and brown spots.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2020
  2. Study start1 May 2021
  3. Primary completion1 Jan 2022
  4. Study completion1 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04630418
Sponsor's protocol ID
20-2033
Status last verified
Dec 2023
First submitted
22 Oct 2020
Last updated
14 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing NanoSilk Cosmo in people with Aging, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective patient perception of skin (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in